We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Impaired Wound Healing in Diabetic Foot Ulceration (EPC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00739323
Recruitment Status : Completed
First Posted : August 21, 2008
Last Update Posted : March 1, 2017
Information provided by (Responsible Party):

Study Description
Brief Summary:
An observational study to gather information about people who may have certain abnormalities in skin microcirculation and muscle metabolism and to determine whether these abnormalities affect wound healing. The study also examines the association of a specific type of cell with the rate of wound healing.

Condition or disease
Diabetes Mellitus Healthy Volunteers

Detailed Description:
An observational study which entails: medical history; physical examination; blood tests; MRI; microcirculation tests (two noninvasive tests: 1) a procedure that measures the resting blood flow of the skin and 2) a technique that introduces acetylcholine and sodium nitroprusside in the skin and measures the ability of the skin's vessels to dilate and increase blood flow); and macrocirculation tests (noninvasive ultrasound of arm). This study also involves 2 Visits to the Beth Israel Deaconess Medical Center in Boston, MA. (Joslin-Beth Israel Deaconess Foot Center, Lowry Outpatient Laboratory, MRI Suite).

Study Design

Study Type : Observational
Actual Enrollment : 137 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Impaired Wound Healing in Diabetic Foot Ulceration
Study Start Date : December 2006
Primary Completion Date : September 2012
Study Completion Date : September 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   21 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Subjects may be selected from the Beth Israel Deaconess Foot Clinic or from the Boston area and surrounding locations.

Inclusion Criteria:

  • Current diagnosis of Type I or Type II Diabetes Mellitus.
  • Ulcer present for minimum 4 weeks
  • Have adequate circulation to the foot
  • Can return for follow-up visits
  • Be able to read and sign the Informed Consent form before enrollment

Exclusion Criteria:

  • Active Charcot's foot ulcer on the foot to be studied
  • Presence of any serious disease that can affect wound healing including end stage renal failure requiring hemodialysis or renal transplantation, active malignant disease requiring treatment, hepatic, hematologic, neurologic, or immune disease
  • Alcohol or drug abuse problems
  • Treatment with oral or parenteral corticosteroids, immunosuppressive or cytotoxic agents
  • Presence of infectious disease that can preclude EPC measurements (including HIV, Hepatitis B and C)
  • Pregnancy
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00739323

United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Principal Investigator: Aristidis Veves, DSc Beth Israel Deaconess Medical Center
More Information

Responsible Party: Aristidis Veves, Rongxiang Xu, MD Professor of Surgery in the Field of Regenerative Therapeutics, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT00739323     History of Changes
Other Study ID Numbers: 2006P000335
R01DK076937 ( U.S. NIH Grant/Contract )
1R01DK076937 ( U.S. NIH Grant/Contract )
First Posted: August 21, 2008    Key Record Dates
Last Update Posted: March 1, 2017
Last Verified: February 2017

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Leg Ulcer
Skin Ulcer
Skin Diseases
Diabetes Complications
Diabetic Neuropathies
Foot Diseases